{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T18:54:56Z","timestamp":1672426496395},"reference-count":22,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2002]]},"DOI":"10.5387\/fms.48.85","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T23:53:30Z","timestamp":1389225210000},"page":"85-92","source":"Crossref","is-referenced-by-count":1,"title":["ANTIKERATIN ANTIBODIES IN SERA OF PATIENTS WITH CONNECTIVE TISSUE DISEASE AND LIVER DISEASE"],"prefix":"10.5387","volume":"48","author":[{"given":"ISAO","family":"TAKEDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HARUYO","family":"IWADATE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOTA","family":"SUGISAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"KANNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOTARO","family":"SHINZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REIJI","family":"KASUKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Amblin TJ, Antikeratin antibodies in rheumatoid arthritis. Br Med J, <b>2<\/b>, 97-99, 1978.","DOI":"10.1136\/bmj.2.6182.97"},{"key":"2","unstructured":"2. Mallya RK, Young BJJ, Pepys MB, Hamblin TJ, Mace BEW, Hamilton EBD, Antikeratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Clin Exp Immunol, <b>51<\/b>, 17-20, 1983."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vincent C, Serre G, Basile J-P, Lestra HC, Girbal E, Sebbag M, Soleihavoup JP, Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called antikeratin antibodies) in rheumatoid arthritis. Clin Exp Immunol, <b>81<\/b>, 83-89, 1990.","DOI":"10.1111\/j.1365-2249.1990.tb05295.x"},{"key":"4","unstructured":"4. Kessel A, Rosner I, Zuckermann E, Golan TD, Toubi E, Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarhritis associated with hepatitis C infection. J Rheumatol, <b>27<\/b>, 610-612, 2000."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Iwatsuki K, Viae K, Reano A, Morera A, Staquet M-J, Thivolet J, Monier JC, Comparative studies on naturally occurring antikeratin antibodies in human sera. J Invest Dermatol, <b>87<\/b>, 179-184, 1986.","DOI":"10.1111\/1523-1747.ep12695322"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Aoki S, Yaoita H, Kikajima Y, An elevated level of autoantibodies against 48- to 50 kd keratin in the serum of patients with psoriasis. J Invest Dermatol, <b>92<\/b>, 179-183, 1989.","DOI":"10.1111\/1523-1747.ep12276700"},{"key":"7","unstructured":"7. Aho K, von Essen R, Kurki P, Palosuo T, Helioevaara M, Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol, <b>20<\/b>, 1278-1281, 1993."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Aho K, Palosuo T, Lukka M, Kurki P, Isomaeki H, Kautiainen H, von Essen R, Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol, <b>28<\/b>, 113-116, 1999.","DOI":"10.1080\/030097499442586"},{"key":"9","unstructured":"9. Masson-Bassiere C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol, <b>51<\/b>, 743-746, 1992."},{"key":"10","unstructured":"10. Vincent C, Simon M, Sebbag M, Girbai-Neuhauser E, Durieux J-J, Cantagrel A, Fournie B, Mazicres B, Serre G, Immunoblotting detection of autoantibodies to human epidermis filaggrin: A new diagnostic test for rheumatoid arthritis. J Rheumatol, <b>25<\/b>, 838-846, 1998."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, <b>31<\/b>, 315-324, 1988.","DOI":"10.1002\/art.1780310302"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hochberg MC, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, <b>40<\/b>, 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bohan A, Peter JB, Polymyositis and dermatomyositis (first of two parts). N Engl J Med, <b>292<\/b>, 344-347, 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum, <b>23<\/b>, 581-590, 1980.","DOI":"10.1002\/art.1780230510"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M, Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis, <b>51<\/b>, 743-746, 1992.","DOI":"10.1136\/ard.51.6.743"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, Salama G, Serre G, The cytokeratin filament-aggregating protein filaggrin is the target of the so-called &ldquo;antikeratin antibodies&rdquo;, autoantibodies specific for rheumatoid arthritis. J Clin Invest, <b>92<\/b>, 1387-1393, 1993.","DOI":"10.1172\/JCI116713"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, Serre G, The antinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis specific autoantibodies. J Clin Invest, <b>95<\/b>, 2672-2679, 1995.","DOI":"10.1172\/JCI117969"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Berthelot J-M, Maugars Y, Castagne A, Audrain M, Prost A, Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Ann Rheum Dis, <b>56<\/b>, 123-125, 1997.","DOI":"10.1136\/ard.56.2.123"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, Heikkilae R, Nykaeren M, von Essen R, Purification of filaggrin from human epidermal and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol, <b>115<\/b>, 294-302, 1998.","DOI":"10.1159\/000069460"},{"key":"20","unstructured":"20. Slack SL, Mannik M, Dale BA, Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol, <b>25<\/b>, 847-851, 1998."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lowthert LA, Ku N-O, Liao J, Coulombe PA, Omary MB, Empigen BB, A useful detergent for solubilization and biochemical analysis of keratins. Biochem Biophys Res Commun, <b>206<\/b>, 370-379, 1995.","DOI":"10.1006\/bbrc.1995.1051"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Waechter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Bueschenfelde K-H, Manns M, Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol, <b>11<\/b>, 232-239, 1990.","DOI":"10.1016\/0168-8278(90)90119-C"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:14:38Z","timestamp":1621538078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/48\/2\/48_85\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.48.85","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002]]}}}